Oncology ward over a 14-day period in February 1997. Five had upper respiratory tract infection (URTI) and three had LRTI (see Table 1 ). Of three patients with LRTI, two Respiratory syncytial virus (RSV), a common cause of both upper and lower respiratory tract infection (LRTI)
/l) secondary to induction chemotherapy for AML. This patient was receiving broadribavirin spectrum antimicrobials for suspected pulmonary fungal infection (piperacillin, gentamicin, vancomycin and amphotericin 1 mg/kg) although this was not proven. All with Respiratory syncytial virus (RSV) is a common cause of LRTI complained of breathlessness, had inspiratory both upper and lower respiratory tract infection (LRTI) in crackles on chest auscultation and reduced oxygen satuinfants and children, particularly in winter. RSV LRTI is ration on air (SaO 2 Ͻ 90%). Two demonstrated abnormal rarely described in adults, although it has been reported changes on CXR (left lower zone shadowing in one patient in bone marrow transplant (BMT) recipients, solid organ and bilateral lower zone shadowing in the other), although transplant recipients, and patients with malignancy one hypoxic patient had no focal abnormality on CXR. All immunosuppressed by chemotherapy.
1-7 Previous reports of three patients with LRTI underwent bronchoscopy with RSV pneumonia occurring in BMT recipients or patients broncho-alveolar lavage. RSV was detected by direct with acute leukaemia show a high mortality.
1,2 This high immunofluorescence of bronchial washings using a fluormortality may relate to delays in diagnosis and treatment escein-labelled antibody technique. In light of the cases of of the disease. Ribavirin, an antiviral agent used in the treat-RSV LRTI, all patients (inpatients and outpatients attending ment of RSV infection in infants and children, has been the unit) were screened for RSV if they had respiratory used with some success in immunocompromised adults symptoms. Five patients had symptoms of URTI (three outwith RSV disease, although this is an unlicensed indipatient, two inpatient). In these five, the diagnosis was cation. 3, 6, 7 We report an outbreak of RSV infection occurmade from direct immunofluorescence of nasopharyngeal ring in a Haemato-Oncology ward which emphasises the wash (NPW) specimens. Three with URTI were transplant importance of early detection and treatment of this recipients (two matched related, one matched unrelated, all infection. outpatients). All five with URTI had normal CXR and none were hypoxic. Patients with RSV infection were isolated from other Case report immunocompromised patients by transfer to another ward and cohort nursed in a ward bay. Simple hygiene measures Eight patients (mean age 42 years, range 22-66) developed (hand washing with chlorhexidine surgical scrub, wearing evidence of RSV infection in a 12-bedded Haematogloves, the use of disposable plastic aprons) were taken to avoid cross-infection. Children under 12 years were not 
Refers to days post-transplant. b Hypoxia was defined as SaO 2 Ͻ90% on air.
undertaken unless there were clinical symptoms; no staff afebrile and not deemed to be immunocompromised. She recovered without specific therapy over a period of 5-7 were documented to have RSV infection during the outbreak. Ribavirin was administered in a short duration days. schedule (2 g three times daily for a total of 3 days) via a small particle aerosol generator (SPAG; ICN Pharmaceuticals, High Wycombe, UK). Ribavirin was used to treat all Discussion three patients with LRTI and the three transplant recipients with URTI. A patient with NHL who had febrile neutro-RSV is almost certainly under-reported as a cause of both upper and lower respiratory tract infection in the immunopenia associated with RSV URTI was also treated with ribavirin. This patient was also treated with broad-spectrum compromised. High mortality rates (Ͼ70%) are reported in adult BMT recipients and in those with leukaemia.
1, 2, 6, 7 antibiotics. In all cases therapy was commenced within 24 h of diagnosis. All three with LRTI required supplemental However, it is clear from such reports that major contributory factors to this high mortality include delays in both oxygen although none required ventilatory support. Two of three patients with LRTI made a rapid recovery, with fever diagnosis and treatment of the disease. This may reflect a previous lack of appreciation of the gravity of this infeclysis at 24 h and return of oxygen saturation to Ͼ96% on air by the end of 3 days of therapy. In both, repeat NPW tion -in one report some patients with RSV pneumonia received no specific antiviral therapy (all died). 1 The sucspecimens for RSV were negative. One patient with LRTI was slow to respond, with persistence of RSV infection on cessful outcome in our group of patients is probably related to prompt diagnosis and initiation of treatment. Although NPW, and a second course of therapy was administered. This resulted in clinical resolution of symptoms and signs, our patients were all post-engraftment (in the case of the five transplant recipients), this has not previously been radiological improvement on CXR, and clearance of the virus on NPW specimens. Four patients with RSV URTI shown to influence survival. 1 Some clinicians have used a combination of ribavirin and intravenous immunoglobulin who were treated with ribavirin showed rapid improvement in clinical symptoms, particularly in resolution of fever (IVIG) at a dose of 500 mg/kg on alternate days with reported success. 6 This has not been the subject of a ran-(within 24 h). Repeated NPW specimens in three patients following one course of treatment demonstrated clearance domised controlled trial and therefore it is difficult to state with certainty whether the more favourable results obtained of the virus. One patient with RSV URTI improved clinically with one course of ribavirin although repeat NPW reflect efficacy of IVIG or earlier diagnosis and treatment of disease. We did not treat our patients with IVIG since showed persistence of the virus. A second course of ribavirin was given and the virus cleared. A patient suffering almost all responded rapidly to ribavirin alone. However, it seems appropriate to treat very ill patients or those slow from gastric carcinoma had RSV URTI although she was to respond to ribavirin alone with combination therapy. Preof progression of URTI to pneumonia and also in the treatment of those with established pneumonia. vious reports detailing outbreaks of RSV infection in this setting have used comparable doses of ribavirin over a longer duration than we have used. In our cohort, a shorter duration of therapy (3 days, although in two patients this References was repeated) was highly effective with a resultant mortality of zero. Three days therapy is the minimum period
